Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q3 2016 · 10-Q
Revenue$2.96B$2.96B+6.4% vs Q3 2015 Net Income$1.03B$1.03B+7.0% vs Q3 2015 EPS Diluted$4.71$4.71+13.5% vs Q3 2015 Gross Profit$2,538,900,000+2.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flowderived$991,300,000+10.7% Free Cash Flowderived$821,000,000+23.2% Margins · derivedGross margin85.9%−2.9 pt vs Q3 2015
Operating margin48.2%−1.2 pt vs Q3 2015
Net margin34.9%+0.2 pt vs Q3 2015
ended Sep 30, 2016 · filed Oct 26, 2016 · 26 d after period end